AI-based medical device company SHMD announced a strategic memorandum of understanding (MOU) with Seongsu Medical Foundation to establish an 'AI-based brain health management platform and expand digital healthcare services.'
The agreement aims to implement SHMD's advanced medical solutions in local hospitals to enhance early detection and prevention of neurological diseases such as stroke and dementia, while building a digital-based regional preventive healthcare system.
Seongsu Medical Foundation operates Incheon Baik Hospital and Ganghwa BS General Hospital in the Incheon area.
The two organizations plan to collaborate closely in various areas, including the introduction of the AI platform 'BrainCheck' for brain health screening, utilizing AI for stroke risk assessment and cognitive function tests, and monitoring with the wearable cerebral blood flow ultrasound device 'Cereband.'
This partnership will also provide a foundation for SHMD to disseminate clinical evidence obtained from large general hospitals to local medical settings.
The representative stated, "For AI medical technology to transform patient health, not only excellent technology but also a collaborative hospital network is essential. We will build an integrated AI brain health platform and work with Seongsu Medical Foundation to expand it to medical sites nationwide."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.